Alternatives to conventional vaccines--mediators of innate immunity.

Abstract:

:Vaccines have been described as "weapons of mass protection". The eradication of many diseases is testament to their utility and effectiveness. Nevertheless, many vaccine preventable diseases remain prevalent because of political and economic barriers. Additionally, the effects of immaturity and old age, therapies that incapacitate the adaptive immune system and the multitude of strategies evolved by pathogens to evade immediate or sustained recognition by the mammalian immune system are barriers to the effectiveness of existing vaccines or development of new vaccines. In the front line of defence against the pervasiness of infection are the elements of the innate immune system. Innate immunity is under studied and poorly appreciated. However, in the first days after entry of a pathogen into the body, our entire protective response is dependant upon the various elements of our innate immune repertoire. In spite of its place as our initial defence against infection, attention is only now turning to strategies which enhance or supplement innate immunity. This review examines the need for and potential of innate immune therapies.

journal_name

Curr Drug Targets

journal_title

Current drug targets

authors

Eisen DP,Liley HG,Minchinton RM

doi

10.2174/1389450043490703

keywords:

subject

Has Abstract

pub_date

2004-01-01 00:00:00

pages

89-105

issue

1

eissn

1389-4501

issn

1873-5592

journal_volume

5

pub_type

杂志文章,评审
  • Prospectives of Antihypertensive Nano-ceuticals as Alternative Therapeutics.

    abstract:BACKGROUND:Global death rate due to cardiovascular diseases (CVDs) is highest as compared to other ailments. Principal risk factor associated with CVDs is hypertension. Major classes of current antihypertensive (AHT) therapies include angiotensin converting enzyme inhibitors (ACEI), angiotensin receptor blockers (ARBs)...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450117666160711163119

    authors: Niaz T,Hafeez Z,Imran M

    更新日期:2017-01-01 00:00:00

  • C. elegans: an all in one model for antimicrobial drug discovery.

    abstract::One approach to identify new drugs with antimicrobial activities is to screen large libraries of molecules directly for their capacity to block the growth of bacterial or fungal monocultures. A more relevant way to assess both a product's efficacy and its potential cytotoxicity is undoubtedly to use an in vivo infecti...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945011795677854

    authors: Squiban B,Kurz CL

    更新日期:2011-06-01 00:00:00

  • Hedgehog signaling in the normal and neoplastic mammary gland.

    abstract::The hedgehog signal transduction network is a critical regulator of metazoan development. Inappropriate activation of this network is implicated in several different cancers, including breast. Genetic evidence in mice as well as molecular biological studies in human cells clearly indicate that activated signaling can ...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945010792006753

    authors: Visbal AP,Lewis MT

    更新日期:2010-09-01 00:00:00

  • Anti-TNF antibody therapy for inflammatory bowel disease during pregnancy: a clinical review.

    abstract::The incidence of inflammatory bowel disease (IBD; Crohn's disease, ulcerative colitis) is highest during the peak reproductive years, hence the increased concern with the safety of IBD drugs during pregnancy. Over the past 11 years, anti-TNF-alpha antibody therapy has emerged as a treatment approach for refractory IBD...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945010790309885

    authors: El Mourabet M,El-Hachem S,Harrison JR,Binion DG

    更新日期:2010-02-01 00:00:00

  • A Mini Review on the Chemistry and Neuroprotective Effects of Silymarin.

    abstract:BACKGROUND:The plant milk thistle and silymarin has been traditionally used as a natural remedy for the treatment of various ailments including neurological disorders such as Alzheimer's and Parkinson's disease and cerebral ischemia for over 2000 years. OBJECTIVE:In this article we review the neuroprotective effects o...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450117666161227125121

    authors: Devi KP,Malar DS,Braidy N,Nabavi SM,Nabavi SF

    更新日期:2017-01-01 00:00:00

  • PDZ Structure and Implication in Selective Drug Design against Cystic Fibrosis.

    abstract::PDZ domains play an essential role in a number of cellular processes by facilitating protein scaffolding and assembly of protein complexes. These domains consist of 80 to 90 amino acids and are found to recognize short C-terminal sequences of target proteins. Protein complex formation between PDZ target molecules can ...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450116666141219120125

    authors: Holcomb J,Spellmon N,Trescott L,Sun F,Li C,Yang Z

    更新日期:2015-01-01 00:00:00

  • 5-lipoxygenase: a promising drug target against inflammatory diseases-biochemical and pharmacological regulation.

    abstract::5-Lipoxygenase (5-LO) is the key enzyme involved in the synthesis of pro-inflammatory leukotrienes (LTs) and has become a prime target for new drug discovery research and development efforts by the pharmaceutical and biotech industry. The pathophysiological effects of LTs can be modulated by the selective inhibition o...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450114666131209110745

    authors: Anwar Y,Sabir JS,Qureshi MI,Saini KS

    更新日期:2014-04-01 00:00:00

  • Kidney diseases and chemokines.

    abstract::Infiltrating inflammatory cells into the kidney mediate the initiation and progression of damage by direct cytotoxicity, the secretion of soluble factors such as cytokines and proteases, or by the subsequent induction of further immune response. Before leukocytes can exert their effects on renal damage or repair, they...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945006775270213

    authors: Panzer U,Steinmetz OM,Stahl RA,Wolf G

    更新日期:2006-01-01 00:00:00

  • The Role of the Oxysterol/EBI2 Pathway in the Immune and Central Nervous Systems.

    abstract::Oxysterols are pleiotropic messengers interacting with multiple receptor systems. One of the cognate receptors for oxysterols is EBI2, a G protein-coupled receptor highly expressed in the cells of the immune system. Here we discuss the receptor's role in the adapted immunity and inflammation as well as the receptor's ...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450117666160217123042

    authors: Rutkowska A,Dev KK,Sailer AW

    更新日期:2016-01-01 00:00:00

  • Antioxidants as a Potential Preventive and Therapeutic Strategy for Cadmium.

    abstract::Epidemiological studies provide a growing number of evidences that chronic exposure to relatively low levels of cadmium (Cd), nowadays taking place in industrialized countries, may cause health hazard. Thus, growing interest has been focused on effective ways of protection from adverse effects of exposure to this heav...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450116666150506114336

    authors: Brzóska MM,Borowska S,Tomczyk M

    更新日期:2016-01-01 00:00:00

  • Non-Small Cell Lung Carcinoma: An Overview on Targeted Therapy.

    abstract::Non-small cell lung cancer (NSCLC) represents close to 90% of all lung cancers. When diagnosed, most cases are on an advanced and inoperable stage, with limited therapeutic options. Existing therapies have shown to be insufficient and novel strategies are urgently necessary. New advances in understanding the disease a...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450115666140528151649

    authors: Nascimento AV,Bousbaa H,Ferreira D,Sarmento B

    更新日期:2015-01-01 00:00:00

  • Saponins as tool for improved targeted tumor therapies.

    abstract::Saponins are plant glycosides that consist of a steroid, steroid alkaloid or triterpenoid aglycone and one or more sugar chains that are covalently linked by glycosidic binding to the aglycone. Glucose, galactose, glucuronic acid, xylose and rhamnose are commonly bound monosaccharides. Saponins are found in all organs...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945009787354584

    authors: Fuchs H,Bachran D,Panjideh H,Schellmann N,Weng A,Melzig MF,Sutherland M,Bachran C

    更新日期:2009-02-01 00:00:00

  • Carbohydrates and epithelial repair - more than just post-translational modification.

    abstract::Epithelia are the layers of cells that form barriers between external milieu and underlying tissues and thus, are important components of most organs of the body. Epithelial layers of organs, such as the lung, are exposed to various challenges resulting in frequent injury. Epithelial wound healing represents an import...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945006776818719

    authors: Allahverdian S,Patchell BJ,Dorscheid DR

    更新日期:2006-05-01 00:00:00

  • Phenothiazines and structurally related compounds as modulators of cancer multidrug resistance.

    abstract::Phenothiazines and structurally related compounds alongside their other biological activities are able to modulate multidrug resistance (MDR) in tumor cells. The extensive investigations on their MDR modulation effects consist part of the efforts to overcome MDR - the major obstacle in cancer chemotherapy. In this art...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945006778226660

    authors: Tsakovska I,Pajeva I

    更新日期:2006-09-01 00:00:00

  • Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders.

    abstract::The adenosine pathway is a powerful evolutionarily selected mechanism aimed at a fine modulation of inflammatory responses and protection of tissues from injuries. Adenosine exerts its modulatory effects via interaction with G protein-coupled receptors, designated as A(1), A(2A), A(2B) and A(3). In this regard, extrac...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945012800564095

    authors: Antonioli L,Colucci R,La Motta C,Tuccori M,Awwad O,Da Settimo F,Blandizzi C,Fornai M

    更新日期:2012-06-01 00:00:00

  • Aceruloplasminemia.

    abstract::Ceruloplasmin contains 95% of the copper in human serum and plays an important role in iron efflux from mammalian cells, including brain cells, due to the activity of ferroxidase, which oxidizes ferrous iron following its transfer to the cell surface via the iron transporter, ferroportin, and delivers ferric iron to e...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945012802002320

    authors: Kono S

    更新日期:2012-08-01 00:00:00

  • Trabectedin (Yondelis®) as a Therapeutic Option in Gynecological Cancers: A Focus on its Mechanisms of Action, Clinical Activity and Genomic Predictors of Drug Response.

    abstract::The use of predictive biomarkers provides potential individualized cancer therapeutic options to prevent therapy failure as well as serious toxicities. Several recent studies showed that predictive and prognostic biomarkers are a notable personalized strategy to improve patients' care in several cancers. Trabectedin (...

    journal_title:Current drug targets

    pub_type: 杂志文章

    doi:10.2174/1389450121666200128161733

    authors: Souid S,Aissaoui D,Srairi-Abid N,Essafi-Benkhadir K

    更新日期:2020-01-01 00:00:00

  • The complex biology of FOXO.

    abstract::FOXO transcription factors control proliferation, apoptosis, differentiation and metabolic processes. Loss of FOXO function has been identified in several human cancers, and results in increased cellular survival and a predisposition to neoplasia, especially in epithelial cancer. FOXO factors are therefore bona fide t...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945011796150307

    authors: Monsalve M,Olmos Y

    更新日期:2011-08-01 00:00:00

  • Advancement of Mechanisms of Coxsackie Virus B3-Induced Myocarditis Pathogenesis and the Potential Therapeutic Targets.

    abstract::Viral myocarditis is a cardiac disease caused by Group B Coxsackie virus of Enterovirus genus in the Picorna viridae family. It causes heart failure in children, young and adults. Ten Percent (10%) of acute heart failure and 12% of sudden deaths in young and adults who are less than 40 years is due to this viral myoca...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450120666190618124722

    authors: Daba TM,Zhao Y,Pan Z

    更新日期:2019-01-01 00:00:00

  • Simultaneous interruption of signal transduction and cell cycle regulatory pathways: implications for new approaches to the treatment of childhood leukemias.

    abstract::The last decade has witnessed the introduction of a large number of novel, molecularly targeted agents into the therapeutic armamentarium against diverse forms of cancer, including leukemia. Such agents include signal transduction, cell cycle, histone deacetylase, Hsp90, proteasome, and Bcl-2 family member inhibitors,...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945007780830764

    authors: Grant S,Dent P

    更新日期:2007-06-01 00:00:00

  • Is surfactant a promising additive drug in ALI/ARDS-patients?

    abstract::The rationale for surfactant replacement therapy in patients with acute respiratory distress syndrome (ARDS) is to restore the normal composition of the surfactant system, as well as to overcome ongoing inactivation of present surfactant. Indeed, surfactant replacement therapy can normalize the composition of the surf...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450043345399

    authors: Schultz MJ,Kesecioglu J

    更新日期:2004-07-01 00:00:00

  • PPARs: a potential target for a disease-modifying strategy in stroke.

    abstract::Stroke is one of the major causes of mortality and disability in adults in industrialized countries. Despite numerous preclinical studies and clinical trials in the field of cerebral ischemia, no pharmacological agent has been validated in the treatment of acute ischemic, except thrombolysis. Cerebral ischemia is not ...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450111314070005

    authors: Ouk T,Potey C,Gautier S,Bastide M,Deplanque D,Staels B,Duriez P,Leys D,Bordet R

    更新日期:2013-06-01 00:00:00

  • Key targets and relevant inhibitors for the drug discovery of tuberculosis.

    abstract::Tuberculosis (TB) is an infectious disease caused by the pathogen Mycobacterium tuberculosis (M. tuberculosis), killing about two million people worldwide each year. An increase in the prevalence of drug-resistant strains of M. tuberculosis in the past decades has renewed focus on the development of new drugs that can...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450111314060009

    authors: Xiong X,Xu Z,Yang Z,Liu Y,Wang D,Dong M,Parker EJ,Zhu W

    更新日期:2013-06-01 00:00:00

  • Advances in antiplatelet therapy for stroke prevention: the new P2Y12 antagonists.

    abstract::Thrombus formation at a site of arterial injury (eg, rupture of an atherosclerotic plaque in a carotid artery), a crucial step in the pathogenesis of cerebral ischemia, is initiated by the adhesion of platelets to the arterial wall. In vivo, activated platelets release adenosine diphosphate (ADP), whose binding to the...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945010790711987

    authors: Giossi A,Pezzini A,Del Zotto E,Volonghi I,Costa P,Ferrari D,Padovani A

    更新日期:2010-03-01 00:00:00

  • Hepatitis C virus proteins as targets for drug development: the role of bioinformatics and modelling.

    abstract::Hepatitis C virus (HCV), a member of the Flaviviridae family, has been recognised to be responsible for both parenterally transmitted and sporadic non-A and non-B hepatitis affecting 1-3% of the world population. HCV is a positive stranded RNA virus encoding a single polyprotein which contains at least ten unique stru...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450023347650

    authors: Lahm A,Yagnik A,Tramontano A,Koch U

    更新日期:2002-08-01 00:00:00

  • Recent advances in targeted anti-vasculature therapy: the neuroblastoma model.

    abstract::Novel anti-vasculature strategies that are emerging for the treatment of cancer and for the inhibition of angiogenesis may be a promising new tool for the adjuvant therapy of malignant tumours. Over the last fifteen years, several reports have been published concerning the relationship between tumour progression and a...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945009789577954

    authors: Pastorino F,Di Paolo D,Loi M,Becherini P,Caffa I,Zorzoli A,Marimpietri D,Carosio R,Perri P,Montaldo PG,Brignole C,Pagnan G,Ribatti D,Allen TM,Ponzoni M

    更新日期:2009-10-01 00:00:00

  • The Role of Type 2 Fibroblast Growth Factor in Periodontal Therapy.

    abstract::The prevalence of periodontitis is around 20-50% of global population. If not treated, it can cause of tooth loss. Periodontal treatment aims at preserving the patient's teeth from various methods, including infection control and restoring lost periodontal tissue. The periodontium has great biological regenerative pot...

    journal_title:Current drug targets

    pub_type: 杂志文章

    doi:10.2174/1389450121999201105152639

    authors: Mohammadipour HS,Forouzanfar F,Forouzanfar A

    更新日期:2020-11-05 00:00:00

  • Multidrug transporters as drug targets.

    abstract::Transport molecules can significantly affect the pharmacodynamics and pharmacokinetics of drugs. An important transport molecule, the 170 kDa P-glycoprotein (Pgp), is constitutively expressed at several organ sites in the human body. Pgp is expressed at the blood-brain barrier, in the kidneys, liver, intestines and in...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945006778019264

    authors: Liang XJ,Aszalos A

    更新日期:2006-08-01 00:00:00

  • Novel Antigen Targets for Immunotherapy of Acute Myeloid Leukemia.

    abstract::Acute myeloid leukemia (AML) was the first malignancy for which immunotherapy, in the form of allogeneic hematopoietic stem cell transplantation (allo-HSCT), was integrated into the standard of care. Allo-HSCT however is an imperfect therapy associated with significant morbidity and mortality while offering only incom...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450116666150223120005

    authors: Goswami M,Hourigan CS

    更新日期:2017-01-01 00:00:00

  • State of the art: psychotherapeutic interventions targeting the psychological factors involved in IBD.

    abstract::The present article aims to review the literature on the relationship between psychology and inflammatory bowel disease (IBD). In particular, the first section is dedicated to explore the role of psychological factors in the etiopathology of the disease, its development and the efficacy of treatments, while the second...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450115666140627151702

    authors: Leone D,Menichetti J,Fiorino G,Vegni E

    更新日期:2014-01-01 00:00:00